The intent of this program announcement (PA) is to encourage investigator-initiated applications to study tumor and normal brain cell injury and repair mechanisms induced by brain tumor radiotherapy including stereotactic radiosurgery procedures such as the Gamma Knife, altered fractionation and/or radioenhancing agents, using state-of-the-art neurobiological and neuroimaging approaches.